Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
05/09/2012 | CN102443561A Gene engineering bacterium for efficiently converting Echinocandin B and preparation method thereof |
05/09/2012 | CN102443560A Gene engineering bacterium for high efficiency conversion of echinocandin B and preparation method thereof |
05/09/2012 | CN102443548A Method for producing gamma-carboxylated proteins |
05/09/2012 | CN102443057A Recombinant humanized collagen and its preparation method |
05/09/2012 | CN102443056A Exon deleted variant of epidermal growth factor receptor |
05/09/2012 | CN101928710B Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application |
05/09/2012 | CN101531710B RF1 antigen, preparation method and application thereof |
05/08/2012 | US8173860 Ton-human mammal that expresses a functional transport receptor in the mammary gland during lactation and a transgenic protein in the blood |
05/08/2012 | US8173782 Fusion protein comprising growth hormone and growth hormone receptor |
05/08/2012 | US8173781 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
05/08/2012 | US8173779 Neutralizing human anti-IGFR antibody |
05/08/2012 | US8173778 Antibody to a guanine nucleotide exchange factor |
05/08/2012 | US8173777 Recombinant Factor X with no glycosylation and method for preparing the same |
05/08/2012 | US8173775 Collagen-like protein CLAC, a precursor thereof, and genes encoding the same |
05/08/2012 | US8173429 Characterization of the I-Spomi endonuclease from fission yeast |
05/08/2012 | US8173424 Internalizing ErbB2 antibodies |
05/08/2012 | US8173408 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
05/08/2012 | US8173398 Humanized anti-IL-6 antibodies |
05/08/2012 | US8173396 Methods for reducing gluconoylation of proteins |
05/08/2012 | US8173395 Mussel bioadhesive |
05/08/2012 | US8173394 Systems and methods for protein production |
05/08/2012 | US8173393 Expanding the eukaryotic genetic code |
05/08/2012 | US8173392 In vivo incorporation of unnatural amino acids |
05/08/2012 | US8173378 Methods of using an alpha-1-adrenergic receptor having altered ligand affinity |
05/08/2012 | US8173377 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
05/08/2012 | US8173364 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
05/08/2012 | US8173134 ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them |
05/08/2012 | US8173127 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof |
05/08/2012 | US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies |
05/08/2012 | US8173122 Methods of treatment using antibodies to neutrokine-alpha |
05/08/2012 | US8173121 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
05/08/2012 | CA2421447C Collections of repeat proteins comprising repeat modules |
05/08/2012 | CA2388041C High mannose proteins and methods of making high mannose proteins |
05/08/2012 | CA2284271C A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient |
05/08/2012 | CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
05/08/2012 | CA1341629C Hepatitis c diagnostics and vaccines |
05/03/2012 | WO2012057328A1 Anti-cdh3 antibody having high internalizing capability |
05/03/2012 | WO2012057315A1 High-affinity anti-cdh3 antibody |
05/03/2012 | WO2012057288A1 Novel anti-dr5 antibody |
05/03/2012 | WO2012055162A1 Momordica charantia polypeptide, preparation method therefor and use thereof |
05/03/2012 | WO2012055066A1 Acarbose composition with effect of lowering blood glucose and preparation method thereof |
05/03/2012 | WO2012030068A3 Polypeptide associated with the synthesis of 1-deoxynojirimycin, and a use therefor |
05/03/2012 | WO2012018610A3 Transgenic animals and methods of use |
05/03/2012 | WO2011163478A3 Dual variable domain immunoglobulins and uses thereof |
05/03/2012 | US20120110694 Plant myb transcription factor homologs |
05/03/2012 | US20120110685 Modular dna-binding domains and methods of use |
05/03/2012 | US20120108795 Antibodies Binding Human Collagen II |
05/03/2012 | US20120108790 Truncated Somatostatin Receptors |
05/03/2012 | US20120108657 Disease-associated protein |
05/03/2012 | US20120108533 Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
05/03/2012 | US20120108523 Disease-associated protein |
05/03/2012 | US20120108498 Structural and mechanistic basis for novel compound biosynthesis using the 4-electron hexose oxidase |
05/03/2012 | US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof |
05/03/2012 | US20120107877 Methods and Compositions for Concentrating Secreted Recombinant Protein |
05/03/2012 | US20120107876 Novel fusion tag offering solubility to insoluble recombinant protein |
05/03/2012 | US20120107875 Expression Cassette, Recombinant Host Cell and Process for Producing a Target Protein |
05/03/2012 | US20120107874 Modified Host Cells and Uses Thereof |
05/03/2012 | US20120107873 Method of Producing a Sweet Protein |
05/03/2012 | US20120107872 Thermostable trichoderma cellulase |
05/03/2012 | US20120107871 Method of producing human igg antibodies with enhanced effector functions |
05/03/2012 | US20120107870 Selective enzymatic amidation of c-terminal esters or acids of peptides |
05/03/2012 | US20120107869 Organic compounds |
05/03/2012 | US20120107868 Processes for making protein hydrolysates from animal peptone and for preserving mucosa |
05/03/2012 | US20120107867 Glycopegylated erythropoietin |
05/03/2012 | US20120107857 Di- and Poly-Ubiquitin Deubiquitinase Substrates and Uses Thereof |
05/03/2012 | US20120107856 New Fungal Production System |
05/03/2012 | US20120107828 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles |
05/03/2012 | US20120107452 Aeration systems for horizontal photobioreactors |
05/03/2012 | US20120107372 Recombinant gelatins |
05/03/2012 | US20120107362 Neurotoxins exhibiting shortened biological activity |
05/03/2012 | US20120107355 Method of rapidly producing improved vaccines for animals |
05/03/2012 | US20120107343 Production of recombinant proteins in ciliates and uses thereof |
05/03/2012 | US20120107339 Chimeric Factor H Binding Proteins (fHBP) Containing a Heterologous B Domain and Methods of Use |
05/03/2012 | US20120107325 IL-17 Antagonistic Antibodies |
05/03/2012 | US20120107324 TARGETED BINDING AGENTS DIRECTED TO a5ß1 AND USES THEREOF |
05/03/2012 | US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein |
05/03/2012 | US20120107320 Antibodies specifically directed to the soluble form of ctla-4 |
05/03/2012 | US20120107318 Methods of administering pif agonist peptides and uses thereof |
05/03/2012 | US20120107301 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
05/03/2012 | US20120107283 Human skin equivalents expressing exogenous polypeptides |
05/03/2012 | US20120107244 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611 |
05/03/2012 | US20120107234 Pan-HER Antibody Composition |
05/03/2012 | CA2816291A1 Novel anti-dr5 antibody |
05/03/2012 | CA2815277A1 Novel egfr-binding molecules and immunoconjugates thereof |
05/02/2012 | EP2447372A2 Anti alpha v beta 6 antibodies and uses thereof |
05/02/2012 | EP2447369A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
05/02/2012 | EP2447368A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
05/02/2012 | EP2447367A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
05/02/2012 | EP2447365A1 Cell-free protein synthesis solution, cell-free protein synthesis kit, and protein synthesis method |
05/02/2012 | EP2445930A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
05/02/2012 | EP2445520A1 ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION |
05/02/2012 | EP1804835B9 Multimeric constructs |
05/02/2012 | EP1343822B1 Means for the diagnosis and therapy of ctcl |
05/02/2012 | CN102439163A Humanized anti-cd20 antibodies and methods of use |
05/02/2012 | CN102438652A Antibody formulation |
05/02/2012 | CN102433342A Synthesized duck beta-defensins-2 gene, recombinant plasmid containing gene as well as production methods for recombinant yeast transformant and recombinant duck beta-defensins-2 protein |
05/02/2012 | CN102433265A Recombinant strain for producing reduced glutathione and preparation method for recombinant strain |
05/02/2012 | CN102432668A Method capable of rapidly separating and purifying target recombinant protein by using centrifugal method |
05/02/2012 | CN102429891A Method for preparing low-molecular-weight sheep bone collagen polypeptide calcium chelate microcapsules |
05/02/2012 | CN101955890B Cadmium salt-resistant saccharomyces cerevisiae and application thereof |